M/04/006 – Abbott Laboratories/TheraSense
Proposal whereby Abbott Laboratories (“Abbott”) would acquire all the issued shares of TheraSense, Inc.
|Notification date||Decision date|
|Monday January 26, 2004||Thursday, February 26, 2004|
|Parties Involved||Business activities|
TheraSense develops, manufactures and sells glucose monitoring systems designed to reduce the pain of testing for people with diabetes.
|Economic sector||Media merger|
|Submissions from third parties due by:|
|Phase 1||Phase 2|
|Current status: Completed|
|Preliminary investigation (Phase 1)|
|Authorised Officer Assigned||Contact Details|
Media enquiries: MKC Communications: 01 7038600